Back
Top 0.3%
18.4%
Top 45%
15.2%
Top 0.4%
12.3%
Top 0.4%
11.4%
Top 41%
6.2%
Top 32%
5.2%
Top 25%
4.3%
Top 4%
2.0%
Top 10%
1.6%
Top 10%
1.4%
Top 5%
1.2%
Top 19%
1.2%
Top 0.3%
1.0%
Top 18%
1.0%
Top 11%
1.0%
Top 7%
1.0%
Top 53%
0.7%
Time-Varying Cardiovascular Risk of Febuxostat versus Allopurinol in Gout: A One-stage Meta-analysis
2025-12-30
rheumatology
Title + abstract only
View on medRxiv
Show abstract
ObjectivesWhether febuxostat is associated with an increased cardiovascular risk compared to allopurinol in patients with gout remains controversial, with major randomized trials reporting conflicting results. This study aims to perform a comprehensive meta-analysis using reconstructed individual participant data (IPD) to evaluate the time-varying cardiovascular and mortality risk of febuxostat versus allopurinol in gout. MethodsWe conducted a one-stage individual participant data meta-analysis...
Predicted journal destinations
1
Rheumatology
21 training papers
2
PLOS ONE
1737 training papers
3
Arthritis & Rheumatology
21 training papers
4
Annals of the Rheumatic Diseases
23 training papers
5
Scientific Reports
701 training papers
6
BMJ Open
553 training papers
7
Nature Communications
483 training papers
8
PLOS Medicine
95 training papers
9
Frontiers in Medicine
99 training papers
10
The Journal of Infectious Diseases
137 training papers
11
Hypertension
20 training papers
12
JAMA Network Open
125 training papers
13
Microorganisms
21 training papers
14
Journal of Clinical Medicine
77 training papers
15
Frontiers in Immunology
140 training papers
16
JCI Insight
63 training papers
17
eLife
262 training papers